ARCHIVES

Fluoride Study Update Finds No Increased Risk

This article is from The Cancer Letter archive.

Vol. 16 No. 40 | October 19, 1990

Download PDF Visit The Full Archive

Related Articles

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

October 9, 2009